Lauren Santye, Assistant Editor

Advocacy group helps breast cancer patient overcome fear and channel her anger to battle the disease.

New technique uses chromatin as a way of identifying small molecule drugs for cancer.

Preclinical studies of a combination therapy with birinapant and p38 inhibitors show promise treating AML.

Generic imatinib could significantly reduce health plan expenditures for TKI therapy and fuel change for the management of the TKI class by payers.

Efforts by state legislators seek to reduce prescription opioid abuse and subsequent heroin addiction.

Study finds large number of uninsured individuals in Massachusetts still face hurdles related to cost and eligibility.

Specialty drugs forecast to account for half of overall US medication spending by 2018.

By 2018, specialty drugs are expected to account for half of overall US medication spending.

Before the trial, Sanofi and Regeneron acknowledged the infringement of 7 patent claims on evolocumab (Repatha).

Jury rules in favor of Amgen in trial that challenged the validity of 2 patents on evolocumab (Repatha).

Boosting serotonin may help regulate the immune response to rheumatoid arthritis.

Current standard treatment for advanced ovarian cancer is carboplatin, paclitaxel, and bevacizumab.

Macrophages can penetrate the surrounding walls that protect pancreatic cancer from chemotherapy.

Research supports weekly chemotherapy without bevacizumab in treating advanced ovarian cancer.

Out-of-pocket spending has significant impact on prescription drug adherence in the treatment of RA through Medicare Advantage and Prescription Drug plan.

Tyverb and Herceptin combination shows significant promise treating HER2 positive breast cancer.

Quality of life and overall health concerns plague patients who survive cancer.

Experimental drug shows promise in treatment of pain and dry eye.

Six or more cups of coffee per day associated with a reduced risk in the onset of multiple sclerosis symptoms.

The bacteria porphyromonas gingivalis is found in 61% of patients with esophageal squamous cell carcinoma.

Radiotherapy and panobinostat show promise treating glioblastoma.

Multiple sclerosis, oncology, and inflammatory conditions among the top drivers of specialty pharmacy spending in annual Express Scripts trend report.

Diabetes, inflammation, and high blood cholesterol treatments among top drivers of drug spending in annual Express Scripts report.

Multiple sclerosis, oncology, and inflammatory conditions among the top drivers of specialty pharmacy spending in annual Express Scripts trend report.

Patients with MS also have higher rates for conditions such as high blood pressure, diabetes, heart disease, chronic lung disease, epilepsy, and inflammatory bowel disease.

Refining approach for which patients are eligible for statin prescriptions could lower heart attack risk in younger patients.

New chemoimmunotherapy drugs found to improve survival in patients with CLL.

Significant side effects and the high cost of treatment only extend survival by a month in

Increased inflammation in obese women is thought to increase the risk of breast cancer.

Laser system allows temporary window in blood-brain barrier to effectively target glioblastoma.